Skip to main content
Premium Trial:

Request an Annual Quote

Frank Brown, Matt Hahn, Stephen Edwards, Richard Judson, Imran Shah, Anthony Orlando, Louise Pitcher, Robert Kolodner, David Brailer

Accelrys has appointed Frank Brown as its chief science officer. Brown spent 20 years at Johnson & Johnson, where he mostly served as senior research fellow within the office of the chief information officer. He is currently an adjunct professor at the University of North Carolina, Chapel Hill's School of Pharmacy in the division of medicinal chemistry, where he lectures on molecular modeling and drug design.
Matt Hahn, Accelrys' former chief science and technology officer, will now become vice president of platform strategy and technology. In a filing with the US Securities and Exchange Commission this week, Accelrys said that Hahn is also resigning as general manager of the company’s SciTegic division, effective Oct. 15. Hahn will continue his employment with the company on a part-time basis and will earn $10,000 per month.
According to the SEC filing, Brown will be paid $240,000 per year and will be eligible for a bonus of an additional 40 percent of his annual salary “upon achievement of a combination of corporate and individual performance objectives.”

The US Environmental Protection Agency has announced three new bioinformatics hires. Stephen Edwards has joined as systems biologist within the National Health and Environmental Effects Research Laboratory in Research Triangle Park, NC; Richard Judson has joined as bioinformaticist with the EPA’s National Center for Computational Toxicology; and Imran Shah has been appointed computational systems biologist in the NCCT.
Edwards most recently served as a senior research scientist and research fellow at Merck’s Rosetta Inpharmatics subsidiary. Judson was senior vice president and chief scientific officer at Genaissance Pharmaceuticals and is the founder of GAMA BioConsulting. Shah joins EPA from Icoria, where he was head of computational systems biology and led the development of the company’s metabolomic biomarker discovery pipeline.

Pharm-Olam International has hired Anthony Orlando as vice president of the global data division, which oversees the company's data management and biostatistics services. Orlando has a background at the Food and Drug Administration’s National Center for Toxicological Research and several contract research organizations.
Pharm-Olam has also appointed Louise Pitcher as associate director of clinical data management. Pitcher has worked as a data manager and project manager for the last 10 years for pharmaceutical companies and a CRO.

The US Department of Health and Human Services has appointed Robert Kolodner as interim national coordinator for health information technology. Kolodner comes from the Veterans Health Administration, where he was chief health informatics officer.
Kolodner assumes a post vacated by David Brailer, who resigned as national coordinator for health IT in April. Brailer currently serves as vice-chair of the American Health Information Community, which is charged with making recommendations to the HHS secretary to facilitate the development and adoption of standards-based health IT.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.